Caribou Biosciences, Inc.
CRBU
$1.84
$0.000.00%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 5.30% | 3.85% | 49.08% | -35.28% | -12.68% |
| Total Depreciation and Amortization | -4.84% | 8.08% | -45.93% | 0.17% | -1.60% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -22.86% | -0.83% | -86.98% | 570.53% | 14.63% |
| Change in Net Operating Assets | -365.18% | 232.51% | -354.33% | 137.03% | 65.23% |
| Cash from Operations | -29.58% | 17.32% | 10.87% | 23.06% | -3.54% |
| Capital Expenditure | -133.33% | 287.83% | 72.49% | 59.88% | -101.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 35.50% | 61.90% | -55.16% | -51.50% | 206.80% |
| Cash from Investing | 33.47% | 65.61% | -54.86% | -51.33% | 209.99% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -33.76% | 1,369.31% | 4,516.67% | -98.72% | -87.89% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -33.76% | 1,369.31% | 4,516.67% | -98.72% | -87.89% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -124.92% | 108.65% | -233.42% | -132.12% | 183.71% |